ArticleJournal of cellular and molecular medicine2024

Identification of RFC4 as a potential biomarker for pan-cancer involving prognosis, tumour immune microenvironment and drugs.

Lei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.